IMMUNOGENICITY AND SAFETY OF A THREE-DOSE SARS-COV-2 VACCINATION STRATEGY IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES ON IMMUNOSUPPRESSIVE THERAPY

Kristin Hammersbøen Bjørlykke  1     Ingrid Jyssum  2     Anne Therese Tveter  2     Joseph Sexton  2     Ingrid E. Christensen  2     Trung T. Tran  3     Siri Mjaaland  4     David J. Warren  3     Tore K Kvien  2     Adity Chopra  3     Grete Birkeland Kro  3     Jørgen Jahnsen  1     Ludvig A. Munthe  3     Espen A Haavardsholm  2     Gunnveig Grødeland  3     John Torgils Vaage  3     Sella Aarrestad Provan  2     Guro Løvik Goll  2     Silje Watterdal Syversen  2     Kristin Kaasen Jørgensen  1    
1 Akershus University Hospital, Lørenskog, Norway
2 Diakonhjemmet Hospital, Oslo, Norway
3 Oslo University Hospital, Oslo, Norway
4 Norwegian Institute of Public Health, Oslo, Norway

Topic
IBD, Nurses, Primary Care

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing